Levothyroxine Sodium Tablet
Product Images NDC 51655-924

3 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-924). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)

Image-1 (94052e3d 58b2 4f4b 8223 A47281c1a592 01)
Chemical structure of Levothyroxine Sodium showing iodine-substituted aromatic rings connected by an ether linkage, with an amino acid side chain illustrating the sodium salt form and associated hydration.*
FDA Label Image

Trade Mark (94052e3d 58b2 4f4b 8223 A47281c1a592 02)

Trade Mark (94052e3d 58b2 4f4b 8223 A47281c1a592 02)
FDA Label Image

Label (51655 924 52 Rev A 03 22 Nhc)

Label (51655 924 52 Rev A 03 22 Nhc)
Packaging label for Levothyroxine Sodium Tablets, USP 50 mcg (0.05 mg) oral tablets. The label indicates a quantity of 30 tablets, labeled for prescription use only. Storage instructions advise keeping at 25°C, protecting from light and moisture. The labeler is Northwind Health Company, LLC, with the NDC 51655-924-52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.